Collegium Pharmaceutical, Inc. (COLL) Capital expenditures 2016–2025
Collegium Pharmaceutical, Inc. (COLL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.7MFY2025 · since FY2016: $477,000 → $1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.7M | +5.3% |
| FY2024 | $1.7M | +258.4% |
| FY2023 | $461,000 | -71.6% |
| FY2022 | $1.6M | -16.6% |
| FY2021 | $1.9M | -64.9% |
| FY2020 | $5.5M | -13.9% |
| FY2019 | $6.4M | +17.5% |
| FY2018 | $5.5M | +453.2% |
| FY2017 | $990,000 | +107.5% |
| FY2016 | $477,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice